Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W Howell

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Radioprotection by DMSO against the biological effects of incorporated radionuclides in vivo--Comparison with other radioprotectors and evidence for indirect action of Auger electronsS M Goddu, V R Narra, R S Harapanhalli, et al.
Radiation Research|December 1, 1991
The question of relative biological effectiveness and quality factor for auger emitters incorporated into proliferating mammalian cellsR W Howell, D V Rao, D Y Hou, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1992
Radiotoxicity of some iodine-123, iodine-125 and iodine-131-labeled compounds in mouse testes: implications for radiopharmaceutical designV R Narra, R W Howell, R S Harapanhalli, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2000
Considerations in the selection of radiopharmaceuticals for palliation of bone pain from metastatic osseous lesionsL G Bouchet, W E Bolch, S M Goddu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1995
Radioprotection against biological effects of internal radionuclides in vivo by S-(2-aminoethyl)isothiouronium bromide hydrobromide (AET)V R Narra, R S Harapanhalli, S M Goddu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 4, 2001
Marrow-sparing effects of 117mSn(4+)diethylenetriaminepentaacetic acid for radionuclide therapy of bone cancerA Bishayee, D V Rao, S C Srivastava, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 16, 2000
Marrow toxicity of 33P-versus 32P-orthophosphate: implications for therapy of bone pain and bone metastasesS M Goddu, A Bishayee, L G Bouchet, et al.
Journal of Medicinal Chemistry|November 22, 1996
[125I/127I]iodoHoechst 33342: synthesis, DNA binding, and biodistributionR S Harapanhalli, L W McLaughlin, R W Howell, et al.
Radiation Research|March 1, 1997
Radiotoxicity of gadolinium-148 and radium-223 in mouse testes: relative biological effectiveness of alpha-particle emitters in vivoR W Howell, S M Goddu, V R Narra, et al.
Medical Physics|December 1, 1994
Relative biological effectiveness of 99mTc radiopharmaceuticalsV R Narra, K S Sastry, S M Goddu, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Radioprotection by DMSO against the biological effects of incorporated radionuclides in vivo--Comparison with other radioprotectors and evidence for indirect action of Auger electronsS M Goddu, V R Narra, R S Harapanhalli, et al.
Radiation Research|December 1, 1991
The question of relative biological effectiveness and quality factor for auger emitters incorporated into proliferating mammalian cellsR W Howell, D V Rao, D Y Hou, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1992
Radiotoxicity of some iodine-123, iodine-125 and iodine-131-labeled compounds in mouse testes: implications for radiopharmaceutical designV R Narra, R W Howell, R S Harapanhalli, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2000
Considerations in the selection of radiopharmaceuticals for palliation of bone pain from metastatic osseous lesionsL G Bouchet, W E Bolch, S M Goddu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1995
Radioprotection against biological effects of internal radionuclides in vivo by S-(2-aminoethyl)isothiouronium bromide hydrobromide (AET)V R Narra, R S Harapanhalli, S M Goddu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 4, 2001
Marrow-sparing effects of 117mSn(4+)diethylenetriaminepentaacetic acid for radionuclide therapy of bone cancerA Bishayee, D V Rao, S C Srivastava, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 16, 2000
Marrow toxicity of 33P-versus 32P-orthophosphate: implications for therapy of bone pain and bone metastasesS M Goddu, A Bishayee, L G Bouchet, et al.
Journal of Medicinal Chemistry|November 22, 1996
[125I/127I]iodoHoechst 33342: synthesis, DNA binding, and biodistributionR S Harapanhalli, L W McLaughlin, R W Howell, et al.
Radiation Research|March 1, 1997
Radiotoxicity of gadolinium-148 and radium-223 in mouse testes: relative biological effectiveness of alpha-particle emitters in vivoR W Howell, S M Goddu, V R Narra, et al.
Medical Physics|December 1, 1994
Relative biological effectiveness of 99mTc radiopharmaceuticalsV R Narra, K S Sastry, S M Goddu, et al.
Pageof 9